Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials
Overview of attention for article published in The Lancet Respiratory Medicine, August 2014
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (88th percentile)
Mentioned by
- news
- 3 news outlets
- policy
- 2 policy sources
- 1 X user
- patent
- 2 patents
- f1000
- 1 research highlight platform
- guideline
- 4 clinical guideline sources
Readers on
- mendeley
- 186 Mendeley